SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
मुख्य लेखक: | Meem, Manila |
---|---|
अन्य लेखक: | Akter, Dr. Raushanara |
स्वरूप: | थीसिस |
भाषा: | English |
प्रकाशित: |
Brac University
2023
|
विषय: | |
ऑनलाइन पहुंच: | http://hdl.handle.net/10361/18081 |
समान संसाधन
-
A review on potential of PARP inhibitors in the treatment of prostate cancer
द्वारा: Islam, Saidul
प्रकाशित: (2022) -
RIPK pathway, as a potential target, for cancer treatment - a review
द्वारा: Jahan, Nusrat
प्रकाशित: (2024) -
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
द्वारा: Flora, Sanzida Alam
प्रकाशित: (2024) -
Immunotherapy in the Management of Lung Cancer
द्वारा: Tasnim, Humayra
प्रकाशित: (2022) -
A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
द्वारा: Ratu, Tabassum
प्रकाशित: (2024)